Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19

February 13, 2013 4:18 PM EST Send to a Friend
Get Alerts LGND Hot Sheet
Trade LGND Now!
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q4 EPS of $0.19, versus $0.22 reported last year. Revenue for the quarter came in at $13.6 million, versus $12.9 million reported last year.

For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment